Calpain activation in neurodegenerative diseases: Confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2

Acta Neuropathologica

Volumn 104, Issue 1, 2002, Pages 92-104

  Adamec, Emil ^a   Mohan, Panaiyur ^b   Vonsattel, Jean P ^c   Nixon, Ralph A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Columbia Presbyterian Medical Center ^*  (United States)

Author keywords

Alzheimer's disease; Calpain; Confocal microscopy; Neurodegeneration; Proteolysis

Indexed keywords

ALPHA SYNUCLEIN; CALPAIN; HUNTINGTIN; PROTEIN KINASE; TAU PROTEIN;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ASTROCYTE; CELL SPECIFICITY; CELL TYPE; COILED BODY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DOWN SYNDROME; ENZYME ACTIVATION; ENZYME LOCALIZATION; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMAGING SYSTEM; IMMUNOFLUORESCENCE MICROSCOPY; MALE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; TAUOPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIBODY SPECIFICITY; CALPAIN; DOWN SYNDROME; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HUNTINGTON DISEASE; LEWY BODY DISEASE; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; PICK DISEASE OF THE BRAIN; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0036934648     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-002-0528-6     Document Type: Review

References (79)

1. Adamec E, Mohan PS, Cataldo AM, Vonsattel JP, Nixon RA (2000) Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience 100:663-675
2. Arai T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, Yagishita S, Beach T, Rogers J, Schwab C, McGeer PL (2001) Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 101: 167-173
3. Banik NL, Matzelle DC, Gantt-Wilford G, Osborne A, Hogan EL (1997) Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res 752:301-306
4. Braak H, Braak E (1989) Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 15:13-26
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
6. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C (1989) Differential ultrastructural localization of mye lin basic protein, myelin/oligodendroglial glycoprotein, and 2′, 3′-cyclic nucleotide 3′- phosphodiesterase in the CNS of adult rats. J Neurochem 52:296-304
7. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95-130
8. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA (1996) Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 16:186-199
9. Constantinidis J, Richard J, Tissot R (1974) Pick's disease. Histological and clinical correlations. Eur Neurol 11:208-217
10. Croall DE, Demartino GN (1991) Calcium activated neutral protease calpain system: structure, function, and regulation. Physiol Rev 71:813-847
11. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-1993
12. Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146:1388-1396
13. Fischer I, Romano-Clarke G, Grynspan F (1991) Calpain-mediated proteolysis of microtubule associated proteins MAP1B and MAP2 in developing brain. Neurochem Res 16:891-898
14. George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361-372
15. Gibb WR, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110:1131-1153
16. Gibb WR, Luthert PJ, Janota I, Lantos PL (1989) Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 52:185-192
17. Gibb WR, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112:1171-1192
18. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3:519-526
19. Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564-569
20. Grynspan F, Griffin WR, Cataldo A, Katayama S, Nixon RA (1997) Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res 763:145-158
21. Hata S, Sorimachi H, Nakagawa K, Maeda T, Abe K, Suzuki K (2001) Domain II of m-calpain is a Ca(2+) -dependent cysteine protease. FEBS Lett 501:111-114
22. Hauw JJ, Verny M, Delaere P, Cervera P, He Y, Duyckaerts C (1990) Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett 119:182-186
23. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015-2019
24. Horikawa Y, Oda N, Cox NJ, et al (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175
25. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56: 1095-1097
26. Ishizaki Y, Tashiro T, Kurokawa M (1983) A calcium-activated protease which preferentially degrades the 160-kDa component of the neurofilament triplet. Eur J Biochem 131:41-45
27. Iwamoto N, Thangnipon W, Crawford C, Emson PC (1991) Localization of calpain immunoreactivity in senile plaques and in neurones undergoing neurofibrillary degeneration in Alzheimer's disease. Brain Res 561:177-180
28. Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128-132
29. Johnson GV, Jope RS, Binder LI (1989) Proteolysis of tau by calpain. Biochem Biophys Res Commun 163:1505-1511
30. Johnson GV, Litersky JM, Jope RS (1991) Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J Neurochem 56:1630-1638
31. Kampfl A, Posmantur RM, Zhao X, Schmutzhard E, Clifton GL, Hayes RL (1997) Mechanisms of calpain proteolysis following traumatic brain injury, implications for pathology and therapy: a review and update. J Neurotrauma 14:121-134
32. Keller JN, Hanni KB, Markesbery WR (2000) Impaired proteasome function in Alzheimer's disease. J Neurochem 75:436-439
33. Kertesz A, Kawarai T, Rogaeva E, St. George-Hyslop P, Poorkaj P, Bird TD, Munoz DG (2000) Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54:818-827
34. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105
35. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55: 97-105
36. McCracken E, Hunter AJ, Patel S, Graham DI, Dewar D (1999) Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J Neurotrauma 16: 749-761
37. McIntosh TK, Saatman KE, Raghupathi R, Graham DI, Smith DH, Lee VM, Trojanowski JQ (1998) The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol Appl Neurobiol 24:251-267
38. Melloni E, Pontremoli S (1989) The calpains. Trends Neurosci 11:438-444
39. Mercken M, Grynspan F, Nixon RA (1995) Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett 368:10-14
40. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
41. Mori H, Kondo J, Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235: 1641-1644
42. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Titani K, Ihara Y (1993) Ubiquitin is conjugated with aminoterminally processed tau in paired helical filaments. Neuron 10:1151-1160
43. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, Welsh FA, Siman R (2001) Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol 170:27-35
44. Nieto A, Correas I, Lopez-Otin C, Avila J (1991) Tau-related protein present in paired helical filaments has a decreased tubulin binding capacity as compared with microtubule-associated protein tau. Biochim Biophys Acta 1096:197-204
45. Nixon RA (2000) A "protease activation cascade" in the pathogenesis of Alzheimer's disease. Ann N Y Acad Sci 924:117-131
46. Nixon RA, Saito K-I, Grynspan F, Griffin WR, Katayama S, Honda T, Mohan PS, Shea T, Beermann ML (1994) Calcium-activated neutral proteinase calpain system in aging and Alzheimer disease. Ann N Y Acad Sci 747:77-91
47. Novak M, Jakes R, Edwards PC, Milstein C, Wischik CM (1991) Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.5 1. Proc Natl Acad Sci USA 88:5837-5841
48. Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669-673
49. Patrick GN, Zukerberg L, Nikolic M, Monte S de la, Dikkes P, Tsai LH (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-622
50. Persichetti F, Ambrose CM, Ge P, et al (1995) Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Mol Med 1:374-383
51. Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C, Sandri F, Pieri F, Leoncini L, Falini B (1997) Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 183:116-123
52. 2+-requiring proteinase. J Biol Chem 261:8309-8313
53. Potter DA, Tirnauer JS, Janssen R, Croall DE, Hughes CN, Fiacco KA, Mier JW, Maki M, Herman IM (1998) Calpain regulates actin remodeling during cell spreading. J Cell Biol 141: 647-662
54. Rebeiz JJ, Kolodny EH, Richardson EPJ (1968) Corticodentatonigral degeneration with neuronal archromasia. Arch Neurol 18:20-33
55. Richard I, Broux O, Allamand V, et al (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81:27-40
56. Richard I, Roudaut C, Saenz A, et al (1999) Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet 64:1524-1540
57. Saito K-I, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase calpain in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90:2628-2632
58. Selznick LA, Holtzman DM, Han BH, Gokden M, Srinivasan AN, Johnson EM Jr, Roth KA (1999) In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 58:1020-1026
59. Sergeant N, Wattez A, Delacourte A (1999) Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively "exon 10" isoforms. J Neurochem 72:1243-1249
60. Shea TB, Spencer MJ, Beermann ML, Cressman CM, Nixon RA (1996) Calcium influx into human neuroblastoma cells induces Alz-50 immunoreactivity: involvement of calpain-mediated hydrolysis of protein kinase C. J Neurochem 66:1539-1549
61. Shields DC, Banik NL (1999) Pathophysiological role of calpain in experimental demyelination. J Neurosci Res 55:533-541
62. Shields DC, Schaecher KE, Saido TC, Banik NL (1999) A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc Natl Acad Sci USA 96: 11486-11491
63. Shimohama S, Suenaga T, Araki W, Yamaoaka Y, Shimizu K, Kimura J (1991) Presence of calpain II immunoreactivity in senile plaques in Alzheimer's disease. Brain Res 558:105-108
64. Sorimachi H, Saido TC, Suzuki K (1994) New era of calpain research. Discovery of tissue-specific calpains. FEBS Lett 343: 1-5
65. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K, Lassmann H (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease: evidence for apoptotic cell death. Am J Pathol 155:1459-1466
66. Steele JC, Richardson J, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333-359
67. Taniguchi S, Fujita Y, Hayashi S, Kakita A, Takahashi H, Murayama S, Saido TC, Hisanaga S, Iwatsubo T, Hasegawa M (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489:46-50
68. The Lund and Manchester Groups (1994) Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57:416-418
69. Tsuji T, Shimohama S, Kimura J, Shimizu K (1998) m-Calpain (calcium-activated neutral proteinase) in Alzheimer's disease brains. Neurosci Lett 248:109-112
70. Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369-384
71. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577
72. Vonsattel JP, Aizawa H, Ge P, DiFiglia M, McKee AC, MacDonald M, Gusella JF, Landwehrmeyer GB, Bird ED, Richardson EP Jr, Hedley-Whyte ET (1995) An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 54:42-56
73. Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W, Crowther RA (1988) Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 85:4884-4888
74. Wouterlood FG, Van Denderen JC, Blijleven N, Van Minnen J, Hartig W (1998) Two-laser dual-immunofluorescence confocal laser scanning microscopy using Cy2- and Cy5-conjugated secondary antibodies: unequivocal detection of co-localization of neuronal markers. Brain Res Brain Res Protoc 2:149-159
75. Xie H, Johnson GV (1997) Ceramide selectively decreases tau levels in differentiated PC12 cells through modulation of calpain I. J Neurochem 69:1020-1030
76. Xie HQ, Johnson GV (1998) Calcineurin inhibition prevents calpain-mediated proteolysis of tau in differentiated PC12 cells. J Neurosci Res 53:153-164
77. Yamada T, McGeer PL, McGeer EG (1992) Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 135:99-102
78. Yamashima T (2000) Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62:273-295
79. Yang LS, Ksiezak-Reding H (1995) Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur J Biochem 233:9-17